Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Methotrexate 2.5 mg/ml Injection

Active Ingredient:
methotrexate
Company:  
Hospira UK Ltd See contact details
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Educational Materials for Healthcare Professionals: Medicines containing Methotrexate

{healthcare_pro_orange} For Healthcare Professionals
To minimise the risk of overdose from patients incorrectly taking methotrexate daily instead of once weekly for autoimmune diseases
{pdf_link}

Methotrexate Patient Alert Card - Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with methotrexate for conditions including arthritis and psoriasis.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Hospira UK Ltd
Company image
Address
Walton Oaks, Walton-On-The-Hill, Dorking Road, Tadworth, Surrey, KT20 7NS, UK
Medical Information Direct Line
+44 (0)1304 616161
Medical Information Website
http://www.pfizermedicalinformation.co.uk/